-
Flumazenil Injection
×
₵550.001 × ₵550.00
A fixed-dose oral combination of vildagliptin (50 mg) and metformin hydrochloride (500 mg), used to improve glycemic control in adults with type 2 diabetes mellitus as an adjunct to diet and exercise.
Price: ₵9.50 /Tablet
Description:
A fixed-dose oral combination of vildagliptin (50 mg) and metformin hydrochloride (500 mg), used to improve glycemic control in adults with type 2 diabetes mellitus as an adjunct to diet and exercise.
Prescription:
Yes—prescription-only medication.
Therapeutic Category:
Antidiabetic agent, combining a DPP-4 inhibitor (vildagliptin) with a biguanide (metformin).
Active Ingredients / Composition:
Vitamins / Minerals:
None.
Variant:
This strength is 50/500 mg film-coated tablet. Other strengths (e.g., 50/850 mg, 50/1000 mg) also exist.
Consume Type:
Oral tablet.
Directions / Usage:
Common Side Effects:
Package Type:
Typically available in blister packs/strips (e.g., 15 tablets).
Storage Advice:
Store in a cool, dry place—below about 30 °C, protected from heat and moisture.
Safety Advice:
Product Substitutes:
Other fixed-dose combinations of vildagliptin + metformin (e.g., 50/850 mg or 50/1000 mg), or use individual components separately. Other classes include DPP-4 inhibitors (e.g., sitagliptin), SGLT-2 inhibitors, sulfonylureas, and insulin depending on patient needs.
Manufacturer / Marketer:
In India, commonly manufactured by Novartis India Ltd (e.g., marketed versions under brand names like Eucreas).
Country of Origin:
In some markets (e.g., India), marketed tablets are manufactured in Turkey.
Do you have any questions? Do not hesitate to contact us.
Reviews
There are no reviews yet.